Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-09
2007-10-09
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S300100, C548S301700, C548S302700, C548S309700, C514S385000
Reexamination Certificate
active
10494897
ABSTRACT:
The invention relates to compounds of the general formulawherein R1, R2, R3, R4, R5, R6, R7, X, Y and a have the significances given in the patent, and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling parasites on warm-blooded animals.
REFERENCES:
patent: 0 953 565 (1999-11-01), None
Gianluca Araldi et al., “Synthesis and Receptor Binding Affinity of Cholecystokinin Receptor Ligands: 2-and 1-indolyl Derivatives of PD134308”, Farmaco, vol. 51, No. 7, pp. 471-476, (1996).
Ducray Pierre
Goebel Thomas
Novartis Animal Health US Inc.
Shameem Golam M. M.
Womble Carlyle Sandridge & Rice PLLC
LandOfFree
Benzimidazol- or indol-aminoacetonitrile derivatives for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazol- or indol-aminoacetonitrile derivatives for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazol- or indol-aminoacetonitrile derivatives for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3856985